With the best-selling medication in the world, tirzepatide, and a record-setting $1 trillion valuation to go with it, Eli ...

A new report looks at Chinese biotech innovation capturing the attention of pharmaceutical executives and investors worldwide ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...

Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...

Unexpected delays, infighting and a staffing crisis are fueling investors’ unease.

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.

Promoting innovation through capital-market innovation and regulatory modernisation, like China did, is the way to go ...

Moleculin Biotech (MBRX) announced it has entered into a research and material transfer agreement with CIC biomaGUNE, a non-profit research ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

The industry’s mRNA alliance is demanding steady FDA leadership, warning that the current “unprecedented turmoil” at the ...

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemias ...